Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-01-21

Clinical Trial Update: Long-term Potentiation Disruption Underlying Cognitive Impairment in ECT [EARLY_Phase 1]

View source ↗

Summary

An EARLY Phase 1 clinical trial investigating long-term potentiation disruption underlying cognitive impairment in electroconvulsive therapy has been withdrawn.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of New Mexico | Conditions: Major Depressive Disorder, Bipolar Disorder II | EARLY_Phase 1 | Status: WITHDRAWN